Gastrointestinal Devices Market Report 2025

The gastrointestinal devices market size has grown strongly in recent years. It will grow from $11.11 billion in 2024 to $11.79 billion in 2025 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to medical education and training, cost-effectiveness and value proposition, disease prevalence and demographic changes, patient-centric approach, regulatory milestones and approvals.

The gastrointestinal devices market size is expected to see strong growth in the next few years. It will grow to $16.38 billion in 2029 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to value-based healthcare initiatives, homecare and patient-centric devices, personalized and precision medicine, global market expansion, regulatory changes and compliance. Major trends in the forecast period include minimally invasive procedures, rising gastrointestinal disorders, shift towards homecare devices, patient-centric approaches, remote monitoring and telemedicine.

The growth of the gastrointestinal devices market is being fueled by the increasing prevalence of gastrointestinal diseases. Gastrointestinal diseases, such as irritable bowel syndrome, hemorrhoids, perianal abscesses, colon polyps, and cancer, among others, are on the rise. The Endoscopy Centre reports that annually, 62 million Americans are diagnosed with some form of digestive disease, with an estimated three to five lakhs Americans suffering from inflammatory bowel disease (IBD), accounting for 2% to 6% of the population. Additionally, the American College of Gastroenterology estimates that 10-15% of the adult population in the USA experiences symptoms of irritable bowel syndrome (IBS). This surge in gastrointestinal diseases has led to an increased demand for gastrointestinal devices, driving the growth of the gastrointestinal devices market.

The growing aging population is anticipated to drive the expansion of the gastrointestinal devices market in the coming years. An aging population refers to a demographic shift characterized by a rising proportion of older individuals within a population, due to lower fertility rates and increased life expectancy. This demographic is more prone to gastrointestinal disorders, resulting in a greater need for devices used in the diagnosis and treatment of such conditions. Older adults face a heightened risk of conditions like colorectal cancer and gastroesophageal reflux disease (GERD). For instance, in January 2024, the Population Reference Bureau, a US-based nonprofit organization, reported that the number of Americans aged 65 and older is expected to grow from 58 million in 2022 to 82 million by 2050. Therefore, the increasing aging population is fueling the growth of the gastrointestinal devices market.

Major companies operating in the gastrointestinal devices sector are strategically expanding their endoscopy solutions portfolio. This expansion involves the development and introduction of new products and services related to endoscopy, a medical procedure that utilizes an endoscope for internal examinations. For example, in January 2023, Fujifilm India Private Limited launched ClutchCutter and FlushKnife, part of a new suite of endoscopy solutions designed for therapeutic gastrointestinal applications. ClutchCutter, a rotatable forceps, combines coagulation, dissection, and incision functions, providing clinicians with versatile capabilities. It features an insulated outer edge for durability and serrated jaws for enhanced grasping capabilities. On the other hand, FlushKnife is a diathermic slitter enabling medical professionals to perform various tasks, including marking, flushing, incision, dissection, and coagulation. The product's ball-tip option enhances traction for effective tissue dissection and coagulation. This strategic focus on expanding endoscopy solutions demonstrates companies' commitment to innovation and competitiveness in the gastrointestinal devices market.

In February 2023, Olympus Corporation, a Japan-based manufacturer of optics and reprography products, completed the acquisition of Taewoong Medical for $370 million. Following the acquisition, Taewoong's portfolio will be integrated into Olympus' therapeutic solutions division. Olympus emphasized the inclusion of Taewoong's extensive line of metallic gastrointestinal (GI) stents, utilized in minimally invasive procedures to address blockages or restrictions in the biliary tract, esophagus, colon, or duodenum caused by conditions such as cancer or digestive system issues. Taewoong Medical, based in South Korea, is a manufacturer of medical devices, including gastrointestinal metallic stents.

Major companies operating in the gastrointestinal devices market include Johnson and Johnson Services Inc., Medtronic plc, Siemens Healthineers AG, Fujifilm Holdings Corporation, Becton, Dickinson and Company, Stryker Corporation, Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, Interscope Inc., Steris plc, Cook Group Incorporated, MICRO-TECH Co. Ltd., Cantel Medical Corp., CONMED Corporation, PENTAX Medical Company, Karl Storz SE & Co. KG, US Endoscopy Inc., Richard Wolf GmbH, Motus GI Holdings Inc., Congentix Medical Inc., ERBE Elektromedizin GmbH, Creo Medical Group plc, GI Dynamics Inc., Millennium Surgical Corp., Mauna Kea Technologies SA, EndoMaster Pte Ltd., Zhanjiang Bokang Biotechnology Co. Ltd., Jinshan Science & Technology Co., Safe Medical Design Inc.

North America was the largest region in the gastrointestinal devices market in 2024. Asia-Pacific was the second largest region in the gastrointestinal devices market report. The regions covered in the gastrointestinal devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the gastrointestinal devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The gastrointestinal devices market consists of sales of instruments such as gastroscope, an enteroscope, and an ultrasound endoscope. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

Gastrointestinal devices encompass tools utilized for diagnosing and treating medical issues concerning the digestive system or the gastrointestinal tract.

Primary gastrointestinal device types include GI videoscopes, biopsy devices, endoscopic retrograde cholangiopancreatography devices (ERCP), capsule endoscopy, endoscopic ultrasound, endoscopic mucosal resection (EMR), hemostasis devices, and others. ERCP involves diagnosing and treating liver, gallbladder, bile duct, and pancreas issues. These devices are distributed through online retailing, medical stores, and brand outlets, catering to hospitals, clinics, dialysis centers, and ambulatory surgical centers.

The gastrointestinal devices market research report is one of a series of new reports that provides gastrointestinal devices market statistics, including gastrointestinal devices industry global market size, regional shares, competitors with a gastrointestinal devices market share, detailed gastrointestinal devices market segments, market trends and opportunities, and any further data you may need to thrive in the gastrointestinal devices industry. The gastrointestinal devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.